CME Group stock gains new Gasoline Decade futures contract
Published on 10/30/2026 at 16:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSNew Futures Contract Sets November Timeline
- CME Group plans to list Gasoline Decade futures on CME Globex and CME ClearPort.
- Customer testing is scheduled to begin on November 15 ahead of the planned November 23 trade date.
- The contract will be listed under NYMEX rules and remains subject to regulatory review.
CME Group plans to expand its energy derivatives offering with Gasoline Decade futures, adding a new product timetable for investors to track. The contract is scheduled to begin trading on CME Globex and become available for clearing through CME ClearPort on Monday, November 23, subject to completion of regulatory review.
Customer testing is scheduled to start on Sunday, November 15. The contracts will be listed under the rules and regulations of NYMEX, according to FX News Group in a report published Thursday, October 29.
What the Product Launch Means
The planned listing broadens CME Group's futures lineup and gives market participants another exchange-traded instrument for managing exposure to gasoline prices. The announced testing date precedes the planned launch by eight days, leaving the timetable dependent on the stated regulatory process.
CME Group stock traded at 273.60 euros on Lang & Schwarz at 16:31 Berlin time on Friday, October 30, 2026. The real-time quote of CME Group stock provides the latest intraday reference.
CME Group Inc. Key Facts
- Company: CME Group Inc.
- ISIN: US12572Q1058
- Ticker: CME
- Lang & Schwarz quote: 273.60 euros at 16:31 Berlin time on October 30, 2026
- Planned product: Gasoline Decade futures
- Customer testing: November 15, 2026
- Planned trade date: November 23, 2026
Broader trading conditions remain relevant for exchange operators as investors assess activity across listed derivatives and related risk-management markets. See the latest S&P 500 market developments.
For more company updates, see more news and analyses on CME Group stock.
